Artemis Therapeutics Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
November 09, 2020 at 03:58 pm EST
Artemis Therapeutics Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced operating loss was USD 28,000 compared to USD 22,000 a year ago. Net loss was USD 29,000 compared to USD 24,000 a year ago. Basic loss per share from continuing operations was USD 0.01. For the nine months, operating loss was USD 104,000 compared to USD 112,000 a year ago. Net loss was USD 56,000 compared to USD 114,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.02 a year ago.